Related references
Note: Only part of the references are listed.Newcastle disease virus strain AF2240 as an oncolytic virus: A review
Jeevanathan Kalyanasundram et al.
ACTA TROPICA (2018)
Recombinant oncolytic Newcastle disease virus displays antitumor activities in anaplastic thyroid cancer cells
Ke Jiang et al.
BMC CANCER (2018)
Subchronic toxicity, immunoregulation and anti-breast tumor effect of Nordamnacantal, an anthraquinone extracted from the stems of Morinda citrifolia L
Nadiah Abu et al.
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE (2018)
Newcastle disease virus co-expressing interleukin 7 and interleukin 15 modified tumor cells as a vaccine for cancer immunotherapy
Xiaojing Xu et al.
CANCER SCIENCE (2018)
The molecular mechanism of anticancer action of novel octahydropyrazino[2,1-a:5,4-a]diisoquinoline derivatives in human gastric cancer cells
Natalia Pawlowska et al.
INVESTIGATIONAL NEW DRUGS (2018)
The significance of microsatellite instability in colorectal cancer after controlling for clinicopathological factors
Sanghee Kang et al.
MEDICINE (2018)
Strategy to targeting the immune resistance and novel therapy in colorectal cancer
Wang Gang et al.
CANCER MEDICINE (2018)
Absence of Tumor Necrosis Factor Supports Alternative Activation of Macrophages in the Liver after Infection with Leishmania major
Shanshan Hu et al.
FRONTIERS IN IMMUNOLOGY (2018)
Colorectal Cancer Consensus Molecular Subtypes Translated to Preclinical Models Uncover Potentially Targetable Cancer Cell Dependencies
Anita Sveen et al.
CLINICAL CANCER RESEARCH (2018)
Cytotoxic T Cells and Granzyme B Associated with Improved Colorectal Cancer Survival in a Prospective Cohort of Older Women
Anna E. Prizment et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2017)
Global patterns and trends in colorectal cancer incidence and mortality
Melina Arnold et al.
GUT (2017)
Mechanisms of resistance to anti-EGFR therapy in colorectal cancer
Ben Zhao et al.
ONCOTARGET (2017)
Immunobiology of Newcastle Disease Virus and Its Use for Prophylactic Vaccination in Poultry and as Adjuvant for Therapeutic Vaccination in Cancer Patients
Volker Schirrmacher
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Recent Advances in Nanomaterials for Gene Delivery-A Review
Michael K. Riley et al.
NANOMATERIALS (2017)
Antitumor effects of oncolytic herpes simplex virus type 2 against colorectal cancer in vitro and in vivo
Lei Yin et al.
THERAPEUTICS AND CLINICAL RISK MANAGEMENT (2017)
TGFβ/Smad3 regulates proliferation and apoptosis through IRS-1 inhibition in colon cancer cells
Katie L. Bailey et al.
PLOS ONE (2017)
Heterogeneity of colon cancer: from bench to bedside
Marco C. Merlano et al.
ESMO OPEN (2017)
Interleukin 12 shows a better curative effect on lung cancer than paclitaxel and cisplatin doublet chemotherapy
Ting Yue et al.
BMC CANCER (2016)
Anti-cancer effect of Annona Muricata Linn Leaves Crude Extract (AMCE) on breast cancer cell line
Syed Umar Faruq Syed Najmuddin et al.
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE (2016)
Recombinant Newcastle disease virus (NDV/Anh-IL-2) expressing human IL-2 as a potential candidate for suppresses growth of hepatoma therapy
Yunzhou Wu et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2016)
Tumor-Infiltrating Lymphocytes, Crohn's-Like Lymphoid Reaction, and Survival From Colorectal Cancer
Laura S. Rozek et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
Quercetin-induced apoptosis of HT-29 colon cancer cells via inhibition of the Akt-CSN6-Myc signaling axis
Lin Yang et al.
MOLECULAR MEDICINE REPORTS (2016)
Robust Oncolytic Virotherapy Induces Tumor Lysis Syndrome and Associated Toxicities in the MPC-11 Plasmacytoma Model
Lianwen Zhang et al.
MOLECULAR THERAPY (2016)
Tumor-Infiltrating Lymphocytes, Crohn's-Like Lymphoid Reaction, and Survival From Colorectal Cancer
Laura S. Rozek et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
Adjuvant FOLFOX treatment for stage III colon cancer: how many cycles are enough?
Yi-Jian Tsai et al.
SPRINGERPLUS (2016)
Interleukin-12-expressing oncolytic virus: A promising strategy for cancer immunotherapy
Almohanad A. Alkayyal et al.
JOURNAL OF TAIBAH UNIVERSITY MEDICAL SCIENCES (2016)
Colorectal Cancer Heterogeneity and Targeted Therapy: A Case for Molecular Disease Subtypes
Janneke F. Linnekamp et al.
CANCER RESEARCH (2015)
The consensus molecular subtypes of colorectal cancer
Justin Guinney et al.
NATURE MEDICINE (2015)
Virus-Based Nanoparticles as Versatile Nanomachines
Kristopher J. Koudelka et al.
ANNUAL REVIEW OF VIROLOGY, VOL 2 (2015)
New insights into IL-12-mediated tumor suppression
S. Tugues et al.
CELL DEATH AND DIFFERENTIATION (2015)
Therapeutic potential of oncolytic Newcastle disease virus: a critical review
Shay Tayeb et al.
ONCOLYTIC VIROTHERAPY (2015)
Genetically engineered Newcastle disease virus expressing interleukin-2 and TNF-related apoptosis-inducing ligand for cancer therapy
Fu-Liang Bai et al.
CANCER BIOLOGY & THERAPY (2014)
Interleukin 12: still a promising candidate for tumor immunotherapy?
Witold Lasek et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2014)
In vivo safety, biodistribution and antitumor effects of uPAR retargeted oncolytic measles virus in syngeneic cancer models
Y. Jing et al.
GENE THERAPY (2014)
Bax protein may influence the invasion of colorectal cancer
Anna Pryczynicz et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Oncolytic Adenoviruses in Cancer Treatment
Ramon Alemany
BIOMEDICINES (2014)
IFN-γ Mediates the Antitumor Effects of Radiation Therapy in a Murine Colon Tumor
Scott A. Gerber et al.
AMERICAN JOURNAL OF PATHOLOGY (2013)
Subcutaneous tumor volume measurement in the awake, manually restrained mouse using MRI
Veerle Kersemans et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2013)
Inhibition of pancreatic cancer and potentiation of gemcitabine effects by the extract of Pao Pereira
Jun Yu et al.
ONCOLOGY REPORTS (2013)
Rescue of MHC-1 Antigen Processing Machinery by Down-Regulation in Expression of IGF-1 in Human Glioblastoma Cells
Yuexin Pan et al.
PLOS ONE (2013)
Characterization of Malaysian velogenic NDV strain AF2240-I genomic sequence: a comparative study
Kavitha Murulitharan et al.
VIRUS GENES (2013)
Natural Oncolytic Activity of Live-Attenuated Measles Virus against Human Lung and Colorectal Adenocarcinomas
Nicolas Boisgerault et al.
BIOMED RESEARCH INTERNATIONAL (2013)
Epigenetic and genetic features of 24 colon cancer cell lines
D. Ahmed et al.
ONCOGENESIS (2013)
Oncolytic Newcastle disease virus for cancer therapy: old challenges and new directions
Dmitriy Zamarin et al.
FUTURE MICROBIOLOGY (2012)
Molecular biology of Bax and Bak activation and action
Dana Westphal et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2011)
Caspase-8 and Bid: Caught in the act between death receptors and mitochondria
Chahrazade Kantari et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2011)
Oncolytic adenovirus co-expressing IL-12 and IL-18 improves tumor-specific immunity via differentiation of T cells expressing IL-12Rβ2 or IL-18Rα
I-K Choi et al.
GENE THERAPY (2011)
Low expression of Granzyme B in colorectal cancer is associated with signs of early metastastic invasion
Paul Salama et al.
HISTOPATHOLOGY (2011)
Safety and Clinical Usage of Newcastle Disease Virus in Cancer Therapy
Han Yuen Lam et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2011)
Activation of Cytotoxic and Regulatory Functions of NK Cells by Sindbis Viral Vectors
Tomer Granot et al.
PLOS ONE (2011)
In Vivo Biological Purging for Lymph Node Metastasis of Human Colorectal Cancer by Telomerase-Specific Oncolytic Virotherapy
Toru Kojima et al.
ANNALS OF SURGERY (2010)
Antitumor efficacy of viral therapy using genetically engineered Newcastle disease virus [NDV(F3aa)-GFP] for peritoneally disseminated gastric cancer
Kyo Young Song et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2010)
Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease
W. Ray Kim et al.
HEPATOLOGY (2008)
TUNEL - an efficient prognosis predictor of salivary malignancies
O. Ben-Izhak et al.
BRITISH JOURNAL OF CANCER (2007)
History of oncolytic viruses: Genesis to genetic engineering
Elizabeth Kelly et al.
MOLECULAR THERAPY (2007)
Apoptosis: A review of programmed cell death
Susan Elmore
TOXICOLOGIC PATHOLOGY (2007)
Expression of cell survival/death genes: Bcl-2 and Bax at the rate of colon cancer prognosis
M Paul-Samojedny et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2005)
Smad3 has a critical role in TGF-β-mediated growth inhibition and apoptosis in colonic epithelial cells
SK Mithani et al.
JOURNAL OF SURGICAL RESEARCH (2004)
Share Paper
